ConnectM Reaffirms $62M Increased Implied Equity Value With Buy-Out Group

Contineum Therapeutics, INC. 0.00%

Contineum Therapeutics, INC.

CNTM

As announced on April 3, 2025, the buy-out offer contemplates the acquisition of all outstanding shares of ConnectM at a cash price of $1.60 per share. At the time of the offer, the Buy-Out Group had referenced the Company's shares outstanding as of December 31, 2024, which implied an equity value of approximately $46.5M. ConnectM has since informed the Buy-Out Group that its current shares outstanding total 38,760,828, implying a total equity value of approximately $62.02 million. Upon receiving this information, the Buy-Out Group confirmed its intention to proceed with the $1.60 per share price for the remaining issued and outstanding publicly held common shares of ConnectM.

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via